Motley Fool Asset Management’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.56M Sell
380,630
-16,734
-4% -$221K 0.21% 88
2026
Q1
$5.48M Sell
397,364
-18,392
-4% -$277K 0.24% 90
2025
Q4
$7.5M Sell
415,756
-15,884
-4% -$285K 0.29% 85
2025
Q3
$8M Buy
+431,640
New +$6.78M 0.33% 66

Other funds holding CLBT

Motley Fool Asset Management's CLBT Position: Q2 2026 in Review

Motley Fool Asset Management reduced its Cellebrite (CLBT) stake by 4.2% in Q2 2026, selling an estimated $221K and leaving 380,630 shares worth $5.56M. The position accounts for 0.21% of the portfolio, ranked #88.

Motley Fool Asset Management first reported a position in CLBT in Q3 2025 and has held it in 4 quarters since. The position peaked at $8M in Q3 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Motley Fool Asset Management held 380,630 shares of Cellebrite worth $5.56M as of Q2 2026.
  • Motley Fool Asset Management sold 16,734 Cellebrite shares in Q2 2026, an estimated $221K.
  • Cellebrite made up 0.21% of Motley Fool Asset Management's portfolio in Q2 2026, its #88 holding.
  • Motley Fool Asset Management first reported a position in Cellebrite in Q3 2025 and has held it in 4 quarters since.
  • Motley Fool Asset Management's Cellebrite position peaked at $8M in Q3 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Motley Fool Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.